Study to Assess the Safety of a New GSK Biologicals' GSK2231395A Candidate Vaccine

NCT00849069 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
30
Enrollment
INDUSTRY
Sponsor class

Stopped The study has been stopped for logistic reasons not related to the safety or efficacy of the vaccine.

Conditions

Interventions

Sponsor

GlaxoSmithKline